PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 153 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $646,000 | +103.1% | 80,388 | +88.5% | 0.03% | +100.0% |
| Q1 2018 | $318,000 | +116.3% | 42,638 | +173.3% | 0.01% | +85.7% |
| Q1 2017 | $147,000 | -34.7% | 15,600 | -56.3% | 0.01% | -90.4% |
| Q3 2016 | $225,000 | -83.2% | 35,700 | -88.4% | 0.07% | +21.7% |
| Q1 2016 | $1,340,000 | +143.2% | 307,523 | +241.6% | 0.06% | +130.8% |
| Q4 2015 | $551,000 | +462.2% | 90,023 | +582.6% | 0.03% | +766.7% |
| Q2 2015 | $98,000 | – | 13,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
| Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
| Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
| Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
| BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
| PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
| Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |